N E El-Ashmawy1, E A El-Zamarany2, E G Khedr1, H A El-Bahrawy1, O A El-Feky3. 1. Department of Biochemistry, Faculty of Pharmacy, Tanta University, El-Bahr Street, Tanta, 31527, El-Gharbiya, Egypt. 2. Department of Clinical Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt. 3. Department of Biochemistry, Faculty of Pharmacy, Tanta University, El-Bahr Street, Tanta, 31527, El-Gharbiya, Egypt. dr_ola23@yahoo.com.
Abstract
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the common malignancies, characterized by poor response to conventional therapeutic options. Immunotherapy with dendritic cells (DCs)-vaccines is one of the most successful strategies used for the treatment of HCC. However, the methods applied in the preparation of antigen-loaded DCs are important factors for optimization of DCs vaccines. PURPOSE: The present study was conducted to investigate the effect of HCC-whole tumor cell lysate prepared using rapid repetitive freeze-thaw cycles on the immunogenicity of DCs and evaluate the ability of whole tumor cell lysate-pulsed DCs vaccine to induce a specific cytotoxic T lymphocytes (CTLs) response against HepG2 cell line. METHODS: Immature DCs generated from peripheral blood monocytes were randomized into two groups: control DCs and whole tumor cell lysate-pulsed DCs. Phenotypic analysis of the DCs' cell maturation marker CD83 and co-stimulatory molecule CD86 was performed. HCC-specific cytotoxic activity of CD8+ CTLs was measured in vitro. RESULTS: Loading of DCs with necrotic whole cell lysate resulted in non-significant changes in DCs' expression of CD83, but a significant increase in expression of CD86. In addition, CD8+ CTLs stimulated with whole tumor cell lysate-pulsed DCs showed a high cytotoxic activity that specifically attack HepG2 cells. CONCLUSION: Our findings indicated that pulsation of DCs with whole tumor cell lysate prepared by repetitive freeze-thaw cycles could efficiently enhance the ability of DCs to induce proliferation and clonal expansion of CD8+ CTLs. Data herein, also indicated that whole tumor cell lysate-pulsed DCs triggers a specific CD8+ CTLs against HCC tumor cells.
BACKGROUND:Hepatocellular carcinoma (HCC) is one of the common malignancies, characterized by poor response to conventional therapeutic options. Immunotherapy with dendritic cells (DCs)-vaccines is one of the most successful strategies used for the treatment of HCC. However, the methods applied in the preparation of antigen-loaded DCs are important factors for optimization of DCs vaccines. PURPOSE: The present study was conducted to investigate the effect of HCC-whole tumor cell lysate prepared using rapid repetitive freeze-thaw cycles on the immunogenicity of DCs and evaluate the ability of whole tumor cell lysate-pulsed DCs vaccine to induce a specific cytotoxic T lymphocytes (CTLs) response against HepG2 cell line. METHODS: Immature DCs generated from peripheral blood monocytes were randomized into two groups: control DCs and whole tumor cell lysate-pulsed DCs. Phenotypic analysis of the DCs' cell maturation marker CD83 and co-stimulatory molecule CD86 was performed. HCC-specific cytotoxic activity of CD8+ CTLs was measured in vitro. RESULTS: Loading of DCs with necrotic whole cell lysate resulted in non-significant changes in DCs' expression of CD83, but a significant increase in expression of CD86. In addition, CD8+ CTLs stimulated with whole tumor cell lysate-pulsed DCs showed a high cytotoxic activity that specifically attack HepG2 cells. CONCLUSION: Our findings indicated that pulsation of DCs with whole tumor cell lysate prepared by repetitive freeze-thaw cycles could efficiently enhance the ability of DCs to induce proliferation and clonal expansion of CD8+ CTLs. Data herein, also indicated that whole tumor cell lysate-pulsed DCs triggers a specific CD8+ CTLs against HCC tumor cells.
Authors: Ching-Hung Shen; Oezcan Talay; Vinay S Mahajan; Ilya B Leskov; Herman N Eisen; Jianzhu Chen Journal: Proc Natl Acad Sci U S A Date: 2010-12-13 Impact factor: 11.205
Authors: Sarah E Henrickson; Mario Perro; Scott M Loughhead; Balimkiz Senman; Susanne Stutte; Michael Quigley; Gabriela Alexe; Matteo Iannacone; Michael P Flynn; Shaida Omid; Jonathan L Jesneck; Sabrina Imam; Thorsten R Mempel; Irina B Mazo; W Nicholas Haining; Ulrich H von Andrian Journal: Immunity Date: 2013-09-19 Impact factor: 31.745
Authors: Tobias Flecken; Nathalie Schmidt; Sandra Hild; Emma Gostick; Oliver Drognitz; Robert Zeiser; Peter Schemmer; Helge Bruns; Thomas Eiermann; David A Price; Hubert E Blum; Christoph Neumann-Haefelin; Robert Thimme Journal: Hepatology Date: 2014-02-20 Impact factor: 17.425
Authors: D Reyes; L Salazar; E Espinoza; C Pereda; E Castellón; R Valdevenito; C Huidobro; M Inés Becker; A Lladser; M N López; F Salazar-Onfray Journal: Br J Cancer Date: 2013-08-29 Impact factor: 7.640